BibTex RIS Cite

NEW PSYCHOACTIVE SUBSTANCE USE IN EUROPE: PREVALENCE, PROBLEMS AND RISKS

Year 2017, Volume: Volume 2 Issue: İssue 1 (1) - 2.İnternational Congress Of Forensic Toxicology, 84 - 84, 16.02.2017

Abstract

Within the past
decade, there has been a significant change in the area of drug use in Europe.
Larger numbers of new psychoactive substances (NPS) have emerged on the market.
The number of new drugs reported to the European Monitoring Centre for Drugs
and Drug Addiction (EMCDDA) has increased from six new substances in the year
2004 (EMCDDA, 2005) to 101 new substances in 2014 (EMCDDA, 2015). With these
substances come a unique set of risks and problems for the users, emergency personnel,
and prevention and policy makers. The present presentation’s goal is to shed
light on the extent of NPS consumption in Europe as well as the problems and
the risks associated with these substances.

References

  • Ludwig KRAUS IFT Institut für Therapieforschung, München, Deutschland; Centre for Social Research on Alcohol and Drugs (SoRAD), Stockholm University, Stockholm, Schweden Centre for Social Research on Alcohol and Drugs (SoRAD), Stockholm Universität, Stockholm, Schweden
Year 2017, Volume: Volume 2 Issue: İssue 1 (1) - 2.İnternational Congress Of Forensic Toxicology, 84 - 84, 16.02.2017

Abstract

References

  • Ludwig KRAUS IFT Institut für Therapieforschung, München, Deutschland; Centre for Social Research on Alcohol and Drugs (SoRAD), Stockholm University, Stockholm, Schweden Centre for Social Research on Alcohol and Drugs (SoRAD), Stockholm Universität, Stockholm, Schweden
There are 1 citations in total.

Details

Journal Section Articles
Authors

Ludwig Kraus This is me

Publication Date February 16, 2017
Published in Issue Year 2017 Volume: Volume 2 Issue: İssue 1 (1) - 2.İnternational Congress Of Forensic Toxicology

Cite

APA Kraus, L. (2017). NEW PSYCHOACTIVE SUBSTANCE USE IN EUROPE: PREVALENCE, PROBLEMS AND RISKS. The Turkish Journal Of Occupational / Environmental Medicine and Safety, Volume 2(İssue 1 (1), 84-84.
AMA Kraus L. NEW PSYCHOACTIVE SUBSTANCE USE IN EUROPE: PREVALENCE, PROBLEMS AND RISKS. turjoem. February 2017;Volume 2(İssue 1 (1):84-84.
Chicago Kraus, Ludwig. “NEW PSYCHOACTIVE SUBSTANCE USE IN EUROPE: PREVALENCE, PROBLEMS AND RISKS”. The Turkish Journal Of Occupational / Environmental Medicine and Safety Volume 2, no. İssue 1 (1) (February 2017): 84-84.
EndNote Kraus L (February 1, 2017) NEW PSYCHOACTIVE SUBSTANCE USE IN EUROPE: PREVALENCE, PROBLEMS AND RISKS. The Turkish Journal Of Occupational / Environmental Medicine and Safety Volume 2 İssue 1 (1) 84–84.
IEEE L. Kraus, “NEW PSYCHOACTIVE SUBSTANCE USE IN EUROPE: PREVALENCE, PROBLEMS AND RISKS”, turjoem, vol. Volume 2, no. İssue 1 (1), pp. 84–84, 2017.
ISNAD Kraus, Ludwig. “NEW PSYCHOACTIVE SUBSTANCE USE IN EUROPE: PREVALENCE, PROBLEMS AND RISKS”. The Turkish Journal Of Occupational / Environmental Medicine and Safety VOLUME 2/İssue 1 (1) (February 2017), 84-84.
JAMA Kraus L. NEW PSYCHOACTIVE SUBSTANCE USE IN EUROPE: PREVALENCE, PROBLEMS AND RISKS. turjoem. 2017;Volume 2:84–84.
MLA Kraus, Ludwig. “NEW PSYCHOACTIVE SUBSTANCE USE IN EUROPE: PREVALENCE, PROBLEMS AND RISKS”. The Turkish Journal Of Occupational / Environmental Medicine and Safety, vol. Volume 2, no. İssue 1 (1), 2017, pp. 84-84.
Vancouver Kraus L. NEW PSYCHOACTIVE SUBSTANCE USE IN EUROPE: PREVALENCE, PROBLEMS AND RISKS. turjoem. 2017;Volume 2(İssue 1 (1):84-.